Increased levels of TSPAN7 in patients with acute lymphoblastic leukemia, chronic myeloid leukemia, or acute myeloid leukemia are associated with drug resistance [53]. The gene discussed is TSPAN7; the disease is acute lymphoblastic leukemia.